We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLMA icon
376
Olema Pharmaceuticals
OLMA
$977M
$4M 0.03%
353,018
+138,010
+64% +$1.78M
OKE icon
377
Oneok
OKE
$56.7B
$4M 0.03%
49,834
-4,998
-9% -$365K
SYRE icon
378
Spyre Therapeutics
SYRE
$8.5B
$3.98M 0.03%
+105,000
New +$3.04M
CAG icon
379
Conagra Brands
CAG
$7.42B
$3.97M 0.03%
133,899
-11,326
-8% -$323K
LNG icon
380
Cheniere Energy
LNG
$54.2B
$3.97M 0.03%
24,598
+3,820
+18% +$614K
PCG icon
381
PG&E
PCG
$39B
$3.95M 0.03%
+235,674
New +$3.95M
ABNB icon
382
Airbnb
ABNB
$90.8B
$3.92M 0.03%
23,760
+1,967
+9% +$298K
CEG icon
383
Constellation Energy
CEG
$92.1B
$3.91M 0.03%
21,127
-1,795
-8% -$255K
FCX icon
384
Freeport-McMoran
FCX
$86.2B
$3.9M 0.02%
82,911
+180
+0.2% +$7.27K
FIS icon
385
Fidelity National Information Services
FIS
$24.2B
$3.88M 0.02%
52,285
+4,666
+10% +$304K
EPR icon
386
EPR Properties
EPR
$4.89B
$3.87M 0.02%
+91,196
New +$3.98M
SYY icon
387
Sysco
SYY
$40.8B
$3.84M 0.02%
47,334
+12,123
+34% +$955K
PEG icon
388
Public Service Enterprise Group
PEG
$38.7B
$3.84M 0.02%
57,450
-1,626
-3% -$99.6K
MAC icon
389
Macerich
MAC
$7.4B
$3.82M 0.02%
+221,743
New +$3.62M
BPMC
390
DELISTED
Blueprint Medicines
BPMC
$3.8M 0.02%
40,065
-10,156
-20% -$871K
MSI icon
391
Motorola Solutions
MSI
$72.1B
$3.75M 0.02%
10,573
-154
-1% -$50.7K
MSCI icon
392
MSCI
MSCI
$42.4B
$3.75M 0.02%
6,692
+568
+9% +$319K
AIZ icon
393
Assurant
AIZ
$13.9B
$3.7M 0.02%
19,661
+14,928
+315% +$2.6M
COF icon
394
Capital One
COF
$128B
$3.69M 0.02%
24,808
+1,498
+6% +$203K
RDY icon
395
Dr. Reddy's Laboratories
RDY
$9.8B
$3.67M 0.02%
250,000
+100,000
+67% +$1.46M
KR icon
396
Kroger
KR
$36.7B
$3.65M 0.02%
63,920
+3,810
+6% +$188K
DFS
397
DELISTED
Discover Financial Services
DFS
$3.62M 0.02%
27,637
-104,138
-79% -$11.9M
PSA icon
398
Public Storage
PSA
$61.5B
$3.61M 0.02%
12,458
+2,694
+28% +$772K
PEN icon
399
Penumbra
PEN
$12.6B
$3.61M 0.02%
16,171
-14,402
-47% -$3.56M
ETNB
400
DELISTED
89bio
ETNB
$3.61M 0.02%
310,000
+30,000
+11% +$332K

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.